A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer

Clinical trial NCT04474470 · COMPLETED

Trial details

NCT number: NCT04474470
Sponsor: TyrNovo Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Squamous Cell Carcinoma of Head and Neck Colorectal Adenocarcinoma Metastatic Solid Tumor Recurrent Solid Tumor Head and Neck Cancer

Start date: 2020-09-03
Primary completion: 2024-05-08
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.